AMFI - Registered Mutual Fund Distributor

Curis Lifesciences Limited IPO

Curis Lifesciences Limited IPO

₹ 256000 / 2000 Shares Shares
Minimum Investment

Curis Lifesciences Limited IPO

Issues Price

₹120-128 per equity share

Curis Lifesciences Limited IPO

Open Date

07 Nov 2025

Close Date

11 Nov 2025

Lot Size

1000

Min. Investment

₹ 256000

Issue Price

₹120-128

Listing Date

14 Nov 2025

Issues Size

21,50,000 shares(aggregating up to ₹27.52 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2000 Shares

Offered To Public

2000 Shares

Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Founded In

2020

Managing Director

Dharmesh Dasharathbhai Patel

Parent Organization

Curis Lifesciences Limited IPO

Application for Curis Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹120-128 ₹2,56,000
Individual(max) ₹120-128 ₹2,56,000
SHNI(min) ₹120-128 ₹3,84,000
SHNI(max) ₹120-128 ₹8,96,000
BHNI(min) ₹120-128 ₹10,24,000

Apply for all eligible candidates, Curis Lifesciences Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.7 Out of 5 (8392 Reviews)

KSquare’s service was fast, transparent, and easy to follow. Perfect for someone like me who needed quick access to funds.

Pooja Khurana

Pooja Khurana

Pediatric Nurse

KSquare’s pension guidance was much needed. Their team helped me select the right NPS tier and gave detailed explanations.

Poonam Seth

Poonam Seth

NGO Coordinator

As someone new to investing, KSquare’s SIP guidance has been incredibly helpful. Their platform is user-friendly, and the support team answered all my questions patiently.

Neha Gupta

Neha Gupta

HR Specialist

I’m very happy with the NPS service at KSquare. Their personalized advice gave me the clarity I needed.

Namrata Das

Namrata Das

High School Teacher

I was skeptical about loans on mutual funds, but KSquare provided full clarity and fast execution. Loved the experience!

Ishita Mehra

Ishita Mehra

Research Associate

KSquare stands out with their personalized approach to NRI investing. Their team’s insights and professionalism are unmatched.

Neel Sharma

Neel Sharma

Real Estate Analyst

KSquare’s NPS support was practical and transparent. They helped me compare options and choose what’s best for my future.

Naveen Thakkar

Naveen Thakkar

Chartered Accountant

KSquare’s New Fund Offering system is reliable and easy to follow. Their pre-launch alerts and fund guides helped me confidently choose what’s best for me.

Divya Jaisingh

Divya Jaisingh

Technical Writer

KSquare’s platform helped me diversify and start SIPs in mutual funds that really suit my lifestyle. I love how easy and intuitive everything feels.

Charu Ahuja

Charu Ahuja

Event Producer

KSquare made the loan process so efficient that I didn’t feel stressed at all. Fantastic customer support as well.

Riya Bhattacharya

Riya Bhattacharya

Brand Consultant

FAQ's

Frequenlty Asked Question

Can NRIs invest in NFOs via KSquare?

Yes, most NFOs are open to NRIs subject to fund house guidelines. KSquare helps confirm eligibility for NRIs.

Will I lose ownership of my mutual funds?

No, the mutual funds are just pledged. You continue to retain ownership and can repay the loan to unpledge them.

Are mutual funds taxable in India?

Yes, mutual funds are subject to capital gains tax. Taxation depends on the type of fund and holding period.

How secure is KSquare’s platform for NRI users?

KSquare uses encrypted systems, regulatory safeguards, and secure servers to protect user data and transactions.

Can I track my SIP performance on KSquare?

Yes, KSquare offers detailed tracking tools and insights so you can monitor your SIP performance anytime.

What if I fail to repay the loan on time?

In case of default, the lender may sell pledged mutual fund units. KSquare advises timely repayment to avoid any financial impact.

Can I open multiple NPS accounts?

No, you’re allowed only one NPS Tier I account, which is linked to your Permanent Retirement Account Number (PRAN).

Why should I choose KSquare for my SIP needs?

KSquare offers expert support, real-time tracking, flexible options, and a user-friendly platform to grow your wealth steadily.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.